semaglutide empower Injections DOLive your healthiest semaglutide life with this revolutionary guide to successfully and safely using GLP Empower pharmacy semaglutide: complete guide

Only about one in five large employers currently offer GLP-1s for weight loss, according to a new survey from the Kaiser Family Foundation

The GLP-1 shortage challenges are exacerbated by a lack of accurate, up-to-date, and accessible GLP-1 supply information, Ro co-founder and CEO Zachariah Reitano said in a press release

Semaglutide (Wegovy) received FDA approval for cardiovascular risk reduction in individuals with obesity, marking a significant milestone in cardiovascular disease (CVD) management

A high-protein food strategy works just as well for retatrutide users as it does for other GLP-1 medications

reported an 11% increased risk of GORD in individuals treated with short-acting GLP-1RAs

Certain medications can disrupt gut bacteria, leading to more hydrogen sulfide and sulfur burps